Use of bone turnover markers in postmenopausal osteoporosis

R Eastell, P Szulc - The lancet Diabetes & endocrinology, 2017 - thelancet.com
Bone turnover comprises two processes: the removal of old bone (resorption) and the laying
down of new bone (formation). N-terminal propeptide of type I procollagen (PINP) and C …

Managing osteoporosis in patients on long‐term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research

RA Adler, G El‐Hajj Fuleihan, DC Bauer… - Journal of Bone and …, 2016 - academic.oup.com
Bisphosphonates (BPs) are the most commonly used medications for osteoporosis. This
ASBMR report provides guidance on BP therapy duration with a risk‐benefit perspective …

American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal …

PM Camacho, SM Petak, N Binkley, DL Diab… - Endocrine Practice, 2020 - Elsevier
Objective The development of these guidelines is sponsored by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Bone turnover markers in the diagnosis and monitoring of metabolic bone disease

MB Greenblatt, JN Tsai, MN Wein - Clinical chemistry, 2017 - academic.oup.com
BACKGROUND Disorders of bone metabolism, most notably osteoporosis, are highly
prevalent and predispose to fractures, causing high patient morbidity and mortality …

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

S Vasikaran, R Eastell, O Bruyere, AJ Foldes… - Osteoporosis …, 2011 - Springer
Abstract Summary The International Osteoporosis Foundation (IOF) and the International
Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommend that a marker …

[HTML][HTML] European guidance for the diagnosis and management of osteoporosis in postmenopausal women

JA Kanis, EV McCloskey, H Johansson… - Osteoporosis …, 2013 - Springer
European guidance for the diagnosis and management of osteoporosis in postmenopausal
women | Osteoporosis International Skip to main content SpringerLink Account Menu Find a …

[HTML][HTML] Biochemical markers of bone turnover part I: biochemistry and variability

MJ Seibel - … Clinical biochemist. Reviews/Australian Association of …, 2005 - ncbi.nlm.nih.gov
With the ageing population in most countries, disorders of bone and mineral metabolism are
becoming increasingly relevant to every day clinical practice. Consequently, the interest in …

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

JA Kanis, N Burlet, C Cooper, PD Delmas… - Osteoporosis …, 2008 - Springer
Guidance is provided in a European setting on the assessment and treatment of
postmenopausal women with or at risk from osteoporosis. Introduction The European …

Osteoporosis in men: an Endocrine Society clinical practice guideline

NB Watts, RA Adler, JP Bilezikian… - The Journal of …, 2012 - academic.oup.com
Objective: The aim was to formulate practice guidelines for management of osteoporosis in
men. Evidence: We used the Grading of Recommendations, Assessment, Development, and …

Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the …

JW Hellstein, RA Adler, B Edwards… - The Journal of the …, 2011 - Elsevier
Background This narrative review of osteonecrosis of the jaw in patients with low bone mass
receiving treatment with antiresorptive agents is based on an appraisal of the literature by an …